Tibet Duo Rui Pharmaceutical Co., Ltd. (301075.SZ)
- Previous Close
19.65 - Open
19.60 - Bid 19.67 x --
- Ask 19.68 x --
- Day's Range
19.51 - 20.05 - 52 Week Range
12.60 - 35.54 - Volume
767,754 - Avg. Volume
2,292,296 - Market Cap (intraday)
1.571B - Beta (5Y Monthly) -0.30
- PE Ratio (TTM)
81.83 - EPS (TTM)
0.24 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Apr 27, 2022
- 1y Target Est
--
Tibet Duo Rui Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of chemical pharmaceutical preparations and its raw materials in China. It offers fluid therapy, anesthesiology, analgesic, and first-aid medication products. The company was founded in 2005 and is headquartered in Tibet, China.
www.duoruiyy.com395
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 301075.SZ
Performance Overview: 301075.SZ
Trailing total returns as of 5/20/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 301075.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 301075.SZ
Valuation Measures
Market Cap
1.57B
Enterprise Value
1.33B
Trailing P/E
81.88
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.67
Price/Book (mrq)
2.10
Enterprise Value/Revenue
3.99
Enterprise Value/EBITDA
53.84
Financial Highlights
Profitability and Income Statement
Profit Margin
5.60%
Return on Assets (ttm)
-0.12%
Return on Equity (ttm)
2.06%
Revenue (ttm)
334.67M
Net Income Avi to Common (ttm)
18.73M
Diluted EPS (ttm)
0.24
Balance Sheet and Cash Flow
Total Cash (mrq)
513.29M
Total Debt/Equity (mrq)
34.42%
Levered Free Cash Flow (ttm)
-50.18M
Research Analysis: 301075.SZ
Company Insights: 301075.SZ
301075.SZ does not have Company Insights